G. Haeseler et al., Phenol derivatives accelerate inactivation kinetics in one inactivation-deficient mutant human skeletal muscle Na+ channel, EUR J PHARM, 416(1-2), 2001, pp. 11-18
Altered inactivation kinetics in skeletal muscle Na+ channels due to mutati
ons in the encoding gene are causal for the alterations in muscle excitabil
ity in nondystrophic myotonia. Na+ channel blockers like lidocaine and mexi
letine, suggested for therapy of myotonia, do not reconstitute inactivation
in channels with defective inactivation in vitro. We examined the effects
of four methylated and/or halogenated phenol derivatives on one heterologou
sly expressed inactivation-deficient Paramyotonia congenita-mutant (R1448H)
muscle Na+ channel in vitro. All these compounds accelerated delayed inact
ivation of R1448H-whole-cell currents during a depolarization and delayed a
ccelerated recovery from inactivation. The potency of these effects paralle
led the potency of the drugs to block the peak current amplitude. We conclu
de that the investigated phenol derivatives affect inactivation-deficient N
a+ channels more specifically than lidocaine and mexiletine. However, for a
ll compounds, the effect on inactivation was accompanied by a substantial b
lock of the peak current amplitude. (C) 2001 Elsevier Science B.V. All righ
ts reserved.